Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

GRFS

Grifols SA ADR

Feb 13 • 04:00PM ET

9.32

+0.04 0.43 %

Healthcare • Drug Manufacturers - General • Spain • NASD

Peers: JNJ BMY PFE MRK LLY AMGN GILD BAX ABT CANF

| Held by: IBB BINV KOMP SPDW BSMC CGIC APIE IBBQ BIB AVTM

Index	-	P/E	15.18	EPS (ttm)	0.61	Insider Own	0.06%	Shs Outstand	257.44M	Perf Week	0.43%
Market Cap	2.40B	Forward P/E	8.79	EPS next Y	1.06	Insider Trans	0.00%	Shs Float	257.30M	Perf Month	0.87%
Enterprise Value	15.84B	PEG	0.38	EPS next Q	-	Inst Own	56.39%	Short Float	2.67%	Perf Quarter	7.25%
Income	417.49M	P/S	0.29	EPS this Y	16.42%	Inst Trans	0.84%	Short Ratio	13.87	Perf Half Y	-13.22%
Sales	8.31B	P/B	1.04	EPS next Y	24.80%	ROA	1.82%	Short Interest	6.88M	Perf YTD	-0.32%
Book/sh	8.95	P/C	3.29	EPS next 5Y	23.43%	ROE	6.93%	52W High	11.14 -16.34%	Perf Year	24.77%
Cash/sh	2.83	P/FCF	2.54	EPS past 3/5Y	-8.79% -24.56%	ROIC	2.49%	52W Low	6.19 50.57%	Perf 3Y	-4.21%
Dividend Est.	0.19 (2.02%)	EV/EBITDA	8.05	Sales past 3/5Y	10.19% 6.45%	Gross Margin	38.70%	Volatility	3.01% 2.44%	Perf 5Y	-44.19%
Dividend TTM	0.18 (1.89%)	EV/Sales	1.91	EPS Y/Y TTM	166.96%	Oper. Margin	18.09%	ATR (14)	0.25	Perf 10Y	-36.47%
Dividend Ex-Date	Aug 12, 2025	Quick Ratio	0.93	Sales Y/Y TTM	9.44%	Profit Margin	5.02%	RSI (14)	52.33	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	2.48	EPS Q/Q	161.12%	SMA20	1.01%	Beta	0.66	Target Price	12.35
Payout	0.00%	Debt/Eq	1.87	Sales Q/Q	10.68%	SMA50	1.93%	Rel Volume	0.65	Prev Close	9.28
Employees	23833	LT Debt/Eq	1.76	Earnings	Nov 04 AMC	SMA200	1.12%	Avg Volume	496.10K	Price	9.32
IPO	Jun 02, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	-26.24% -6.10%	Trades		Volume	323,739	Change	0.43%

Date	Action	Analyst	Rating Change
Feb-12-25	Resumed	Morgan Stanley	Overweight
Mar-12-24	Downgrade	Deutsche Bank	Hold → Sell
Apr-12-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Mar-03-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Feb-16-23	Upgrade	Barclays	Underweight → Equal Weight
Jan-18-23	Upgrade	Jefferies	Hold → Buy
Apr-08-22	Initiated	Morgan Stanley	Equal-Weight
Nov-05-21	Downgrade	Deutsche Bank	Buy → Hold
Oct-19-21	Downgrade	Barclays	Overweight → Underweight
Oct-06-21	Upgrade	Citigroup	Neutral → Buy
Jun-14-21	Upgrade	Deutsche Bank	Hold → Buy
Apr-20-21	Initiated	Deutsche Bank	Hold
Mar-23-21	Upgrade	Credit Suisse	Neutral → Outperform
Mar-11-21	Upgrade	HSBC Securities	Hold → Buy
Oct-01-20	Upgrade	Citigroup	Sell → Neutral
Jun-09-20	Upgrade	HSBC Securities	Reduce → Hold
Jun-09-20	Downgrade	Citigroup	Neutral → Sell
Mar-25-20	Downgrade	Citigroup	Buy → Neutral
Jun-27-19	Upgrade	JP Morgan	Neutral → Overweight
Feb-08-19	Downgrade	Berenberg	Buy → Hold

Show Previous Ratings

Jan-22-26 09:13AM	ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? (Zacks)
Nov-06-25 09:35AM	Down 10.4% in 4 Weeks, Here's Why Grifols (GRFS) Looks Ripe for a Turnaround (Zacks)
Nov-04-25 08:13PM	Grifols SA (GRFS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ... (GuruFocus.com) -6.40%
Oct-30-25 09:40AM	Is Grifols (GRFS) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-27-25 11:40AM	GRFS vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Loading…
09:40AM	Are Investors Undervaluing Grifols (GRFS) Right Now? (Zacks)
Oct-10-25 11:40AM	GRFS vs. STVN: Which Stock Should Value Investors Buy Now? (Zacks)
09:40AM	Is Grifols (GRFS) Stock Undervalued Right Now? (Zacks)
Sep-24-25 11:40AM	GRFS or NBIX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Should Value Investors Buy Grifols (GRFS) Stock? (Zacks)
Sep-11-25 11:11AM	Grifols, S.A. (GRFS) to Double Plasma Production With New Spain Facility (Insider Monkey)
Sep-08-25 04:59PM	Should Value Investors Buy Grifols (GRFS) Stock? (Zacks)
Aug-28-25 12:00PM	All You Need to Know About Grifols (GRFS) Rating Upgrade to Buy (Zacks)
Aug-20-25 11:40AM	GRFS or NBIX: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Are Investors Undervaluing Grifols (GRFS) Right Now? (Zacks)
05:43AM	Loading…
Jul-31-25 05:43AM	New Strong Sell Stocks for July 31st (Zacks)
Jun-27-25 08:11AM	Will Strong Asceniv Sales Drive ADMA Biologics Further? (Zacks)
Jun-16-25 01:06PM	ADMA Looks to Expand Asceniv's Label: Will This Boost Sales? (Zacks)
Jun-06-25 10:40AM	ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold? (Zacks)
Jun-05-25 12:00PM	Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know (Zacks)
Jun-03-25 09:40AM	Is Grifols (GRFS) Stock Undervalued Right Now? (Zacks)
Jun-02-25 11:40AM	GRFS vs. STVN: Which Stock Is the Better Value Option? (Zacks)
May-30-25 04:05PM	Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting (Business Wire)
May-28-25 10:01AM	ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy? (Zacks)
May-22-25 05:34AM	FDA clears Grifols application for dry eye disease treatment (Clinical Trials Arena)
May-15-25 11:40AM	GRFS or NBIX: Which Is the Better Value Stock Right Now? (Zacks)
May-13-25 11:48AM	Grifols reports Q1 adjusted EBITDA of EUR 400M, up 14.2% from last year (TipRanks)
11:46AM	Grifols reaffirms guidance for 2025 (TipRanks)
May-08-25 01:26PM	ADMA's Q1 Earnings and Revenues Miss: Buy, Sell or Hold the Stock? (Zacks)
May-01-25 01:22PM	Should ADMA Biologics Stock Be in Your Portfolio Pre-Q1 Earnings? (Zacks)
06:17AM	Loading…
Apr-30-25 06:17AM	Australia's CSL evaluates China tariff exemptions for its US-made drugs (Reuters)
Apr-28-25 08:40AM	Here's White Falcon's Views on Grifols, S.A. (GRFS) (Insider Monkey)
Apr-23-25 11:10AM	Grifols: A Market Setback Turns Into Buying Opportunity (Seeking Alpha)
10:50AM	White Falcon Capital Q1 2025 Partner's Letter (Seeking Alpha)
Apr-09-25 06:32AM	IBL partners with Grifols to develop biomarker panels for speciality diagnostics (Medical Device Network) +6.78%
Apr-02-25 07:27AM	Stocks to Watch Wednesday: Tesla, Nvidia, Newsmax, Novo Nordisk (The Wall Street Journal) +7.61%
03:03AM	Spanish pharma company Grifols' shares up on Brookfield talk (Reuters)
Feb-27-25 09:16AM	Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now? (Insider Monkey)
06:00AM	Grifols SA (GIFLF) (Q4 2024) Earnings Call Highlights: Record Revenues and Strategic ... (GuruFocus.com)
Jan-22-25 10:22AM	Gotham, Grifols Eye Two Separate Regulator Reports Ahead of Legal Standoff (Bloomberg)
Jan-14-25 06:00AM	Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease (GlobeNewswire)
Jan-13-25 10:55AM	Mason Capital complains about Grifols' transparency to Spanish regulator (Reuters)
10:00AM	Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols (Business Wire)
Dec-13-24 05:24AM	Grifols Worst-Ever Year Cant Derail Analyst Calls to Buy (Bloomberg)
04:14AM	Grifols Keeps Door Open to Brookfield With Special Bond Term (Bloomberg)
Dec-10-24 01:07PM	Flat Footed Asks Grifols to Reform Board to Protect Shareholders (Bloomberg)
Dec-06-24 10:34AM	Analyst Report: Grifols, S.A. (Morningstar Research)
Dec-05-24 03:40AM	SEC Drops Probe Into Gotham Over Report on Grifols Accounts (Bloomberg)
Dec-04-24 02:30AM	Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga (Business Wire)
Dec-03-24 05:13AM	Grifols Shareholder Mason Capital Calls for Board Overhaul (Bloomberg)
Nov-29-24 09:29AM	Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday? (Benzinga) -13.38%
Nov-28-24 07:39AM	Billionaire Grifols Family Woes in Focus as Brookfield Exits (Bloomberg)
07:09AM	Grifols In Talks to Refinance Debt, Credit Line, CEO Says (Bloomberg)
Nov-27-24 09:02AM	Brookfield Drops $6.8 Billion Offer to Buy Drugmaker Grifols (Bloomberg) -7.45%
06:58AM	Brookfield Set to Drop Grifols Bid as Family Shuns Others (Bloomberg)
Nov-20-24 07:30AM	GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment (Clinical Trials Arena)
02:16AM	Grifols Signals It Would Reject $6.8 Billion Brookfield Bid (Bloomberg)
Nov-19-24 11:16PM	Analyst Report: Grifols, S.A. (Morningstar Research) -8.24%
08:00AM	GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus (GlobeNewswire)
07:33AM	Brookfield Weighs 6.45 Billion Bid for Grifols; Shares Drop (Bloomberg)
02:30AM	Mason Capital Reiterates Corporate Governance Shortcomings and Mismanagement of Grifols Under Current Board of Directors (Business Wire)
Nov-14-24 11:37AM	Banks to Pitch Roughly 11 Billion Buyout Debt for Grifols (Bloomberg) +5.06%
Nov-08-24 06:01PM	Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ... (GuruFocus.com)
03:54PM	Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors (Business Wire)
10:27AM	Analyst Report: Grifols, S.A. (Morningstar Research)
Nov-05-24 12:02PM	Brookfield Seeks More Information on Grifols Related-Party Deals (Bloomberg) +5.57%
Oct-30-24 08:28AM	Grifols receives FDA approval to treat surgical bleeding with FS solution (TipRanks) +6.95%
Oct-29-24 08:00AM	Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution (GlobeNewswire)
Oct-22-24 08:00AM	Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury (GlobeNewswire)
Oct-03-24 08:00AM	GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat (GlobeNewswire)
Sep-19-24 04:00PM	Grifols Investor Group With 7.7% Holding Seeks Seat on Board (Bloomberg)
Sep-10-24 01:37PM	Grifols Holders Call on Family, Brookfield to Offer Fair Price (Bloomberg)
Sep-03-24 05:41AM	Grifols Postpones Capital Markets Day Amid Potential Takeover (Bloomberg)
Aug-29-24 12:22PM	Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid (Bloomberg)
Aug-26-24 07:00AM	This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future (The Wall Street Journal)
Aug-22-24 11:01AM	Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday (Zacks) +15.38%
Aug-21-24 12:19PM	Brookfield in talks with banks for funding Grifols' takeover bid, sources say (Reuters) +6.68%
05:33AM	Brookfield Seeks Nearly 10 Billion to Back Grifols Takeover (Bloomberg)
05:14AM	Grifols shares up on potential takeover by Brookfield (Investing.com)
Aug-07-24 07:02PM	Azvalor Iberia FI's Strategic Moves in Q2 2024: Spotlight on Linea Directa Aseguradora SA (GuruFocus.com)
Aug-02-24 01:21PM	Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again - Hagens Berman (Business Wire)
Jul-31-24 12:27PM	Grifols: Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339 (GlobeNewswire)
Jul-30-24 07:42PM	Analyst Report: Grifols, S.A. (Morningstar Research)
11:35AM	Grifols Cuts Chinese Stake Value by 457 Million After Audit (Bloomberg)
Jul-29-24 08:00AM	Grifols receives expanded XEMBIFY (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients (GlobeNewswire)
Jul-09-24 11:28AM	Grifols Family Shareholders, Brookfield in Talks To Take Firm Private (Investopedia)
Jul-08-24 01:00PM	3 Stocks to Buy From the Ultimate' Buy-and-Hold Portfolio (InvestorPlace) +19.46%
12:36PM	GRFS Stock Alert: Grifols Pops 20% on Takeover Interest (InvestorPlace)
11:36AM	Analyst Report: Grifols, S.A. (Morningstar Research)
11:16AM	Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why (Benzinga)
07:41AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
06:18AM	Grifols Says Founding Family, Brookfield Weigh Takeover Bid (Bloomberg)
Jul-01-24 06:00AM	Grifols' Biotest to achieve USD 1 billion in US sales of Yimmugo over next seven years (GlobeNewswire)
Jun-18-24 07:30AM	Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group (GlobeNewswire)
Jun-17-24 11:54AM	Biotest wins FDA approval for plasma protein therapy (Pharmaceutical Technology)
10:13AM	Grifols prepares for late-stage plans with plasma-derived medicines in 2024 (Pharmaceutical Technology)
04:20AM	Grifols' Biotest receives FDA approval for innovative Yimmugo immunoglobulin to treat primary immunodeficiencies (GlobeNewswire)
Jun-07-24 03:32PM	Analyst Report: Grifols, S.A. (Morningstar Research)
May-21-24 04:31AM	GigaGen doses first subject in Phase I advanced solid tumour trial (Clinical Trials Arena)

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by Jose Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.

SUPN Supernus Pharmaceuticals Inc daily Stock Chart

Peers: NBIX ACAD TEVA UTHR INSM AXNX PTCT DRRX MNKD XENE

| Held by: IJR VTI IWM VB VBR VXF SPSM IWN IJT SCHA

Index	RUT	P/E	-	EPS (ttm)	-0.34	Insider Own	5.10%	Shs Outstand	57.12M	Perf Week	-1.57%
Market Cap	2.92B	Forward P/E	16.67	EPS next Y	3.05	Insider Trans	-11.00%	Shs Float	54.42M	Perf Month	-1.85%
Enterprise Value	2.68B	PEG	5.07	EPS next Q	0.33	Inst Own	104.99%	Short Float	7.33%	Perf Quarter	13.94%
Income	-19.12M	P/S	4.28	EPS this Y	-4.70%	Inst Trans	-4.62%	Short Ratio	5.88	Perf Half Y	20.56%
Sales	681.54M	P/B	2.77	EPS next Y	1.84%	ROA	-1.38%	Short Interest	3.99M	Perf YTD	2.29%
Book/sh	18.38	P/C	10.37	EPS next 5Y	3.29%	ROE	-1.86%	52W High	57.65 -11.81%	Perf Year	28.61%
Cash/sh	4.90	P/FCF	41.20	EPS past 3/5Y	10.33% -8.87%	ROIC	-1.77%	52W Low	29.16 74.35%	Perf 3Y	28.90%
Dividend Est.	-	EV/EBITDA	51.02	Sales past 3/5Y	4.51% 11.00%	Gross Margin	76.08%	Volatility	3.34% 3.09%	Perf 5Y	66.31%
Dividend TTM	-	EV/Sales	3.93	EPS Y/Y TTM	-130.59%	Oper. Margin	-4.83%	ATR (14)	1.60	Perf 10Y	295.95%
Dividend Ex-Date	-	Quick Ratio	1.56	Sales Y/Y TTM	4.54%	Profit Margin	-2.80%	RSI (14)	55.54	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	1.80	EPS Q/Q	-216.09%	SMA20	2.37%	Beta	0.71	Target Price	61.33
Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	9.34%	SMA50	2.91%	Rel Volume	1.02	Prev Close	49.85
Employees	674	LT Debt/Eq	0.03	Earnings	Feb 24 AMC	SMA200	19.01%	Avg Volume	678.45K	Price	50.84
IPO	May 01, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	70.41% 6.59%	Trades		Volume	695,054	Change	1.99%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-09-25	Upgrade	Piper Sandler	Neutral → Overweight	$65
Jul-30-25	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$42
Feb-19-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$57 → $36
Jan-06-25	Initiated	Cantor Fitzgerald	Overweight	$57
Sep-11-24	Downgrade	Piper Sandler	Overweight → Neutral	$41 → $36
Jan-03-23	Resumed	Jefferies	Buy	$44 → $45
Dec-01-21	Resumed	Jefferies	Buy	$40 → $44
Apr-13-21	Upgrade	Jefferies	Hold → Buy	$25 → $40
Jun-16-20	Upgrade	Piper Sandler	Neutral → Overweight	$25 → $31
Jun-15-20	Resumed	Jefferies	Hold	$24
Nov-08-19	Downgrade	Berenberg	Buy → Hold
Nov-07-19	Downgrade	Stifel	Buy → Hold	$55 → $23
Nov-06-19	Downgrade	Jefferies	Buy → Hold	$46 → $23
Nov-12-18	Reiterated	B. Riley FBR	Buy	$68 → $65
Jan-18-18	Reiterated	B. Riley FBR, Inc.	Buy	$54
Dec-28-17	Reiterated	B. Riley FBR, Inc.	Buy	$50 → $54
Dec-04-17	Upgrade	Janney	Neutral → Buy
Nov-08-17	Upgrade	Stifel	Hold → Buy	$47
Oct-19-17	Initiated	FBR & Co.	Buy	$53
Sep-19-17	Downgrade	Stifel	Buy → Hold	$47

Show Previous Ratings

Feb-12-26 04:35PM	Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026 (GlobeNewswire)
Feb-06-26 11:30AM	BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View (Zacks)
Feb-03-26 07:56AM	New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings (Zacks)
Dec-19-25 06:57AM	Strong Results Lifted Supernus Pharmaceuticals (SUPN) in Q3 (Insider Monkey)
Dec-03-25 04:05PM	Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference (GlobeNewswire)
04:06PM	Loading…
Nov-21-25 04:06PM	Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
11:00AM	Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN) (StockStory)
Nov-12-25 04:05PM	Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London (GlobeNewswire)
Nov-11-25 12:36AM	5 Must-Read Analyst Questions From Supernus Pharmaceuticals's Q3 Earnings Call (StockStory)
Nov-06-25 08:07AM	Supernus Pharmaceuticals (SUPN) is Benefiting from Its Strength in Financial Position (Insider Monkey)
Nov-05-25 12:26PM	Why Supernus Pharmaceuticals (SUPN) Shares Are Trading Lower Today (StockStory) -17.35%
08:37AM	SUPN Q3 Deep Dive: Growth Drivers Offset By Supply Constraints and Integration Costs (StockStory)
12:03AM	Supernus Pharmaceuticals Inc (SUPN) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst ... (GuruFocus.com)
Nov-04-25 08:30PM	Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:20PM	Supernus Pharmaceuticals (SUPN) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:18PM	Loading…
04:18PM	Supernus: Q3 Earnings Snapshot (Associated Press Finance)
04:12PM	Supernus Pharmaceuticals (NASDAQ:SUPN) Surprises With Strong Q3 (StockStory)
04:01PM	Supernus Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-02-25 10:01PM	Supernus Pharmaceuticals (SUPN) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-30-25 02:02PM	BIIB Beats on Q3 Earnings & Sales, Stock Down on Lowered '25 EPS View (Zacks)
10:00AM	Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-29-25 05:15PM	BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
12:00PM	Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to Buy (Zacks)
09:35AM	Skyworks upgraded, UnitedHealth downgraded: Wall Street's top analyst calls (The Fly)
Oct-28-25 10:00AM	Earnings Preview: Supernus Pharmaceuticals (SUPN) Q3 Earnings Expected to Decline (Zacks)
09:14AM	BridgeBio Pharma (BBIO) Soars 17.1%: Is Further Upside Left in the Stock? (Zacks)
Oct-27-25 09:15AM	Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? (Zacks)
Oct-24-25 10:33AM	Will Biogen Beat on Q3 Earnings? Leqembi, Skyclarys Could Hold the Key (Zacks)
Oct-22-25 12:10PM	Why Supernus (SUPN) is Poised to Beat Earnings Estimates Again (Zacks)
Oct-21-25 05:00PM	Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 (GlobeNewswire)
03:23AM	Loading…
Oct-16-25 03:23AM	Zacks.com featured highlights include United Natural Foods, Teladoc Health, Supernus and BRP (Zacks)
Oct-15-25 03:08PM	Can 4 Relative Price Strength Stocks Defy Market Swings? (Zacks)
Oct-13-25 12:00PM	Supernus Pharmaceuticals (SUPN) Is Up 2.81% in One Week: What You Should Know (Zacks)
Oct-12-25 11:31PM	Branded Pharmaceuticals Stocks Q2 Earnings Review: Supernus Pharmaceuticals (NASDAQ:SUPN) Shines (StockStory)
Oct-10-25 11:55AM	Can Biogen Stock Rebound as New Drugs Aim to Offset MS Sales Declines? (Zacks)
09:15AM	Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? (Zacks)
Oct-09-25 12:05PM	Supernus Pharmaceuticals (SUPN) Stock Is Up, What You Need To Know (StockStory)
Sep-25-25 12:00PM	Are You Looking for a Top Momentum Pick? Why Supernus Pharmaceuticals (SUPN) is a Great Choice (Zacks)
Sep-23-25 09:15AM	Supernus Pharmaceuticals, Inc. (SUPN) Hit a 52 Week High, Can the Run Continue? (Zacks)
Sep-18-25 09:17AM	Biogen Gets EU Nod for First Postpartum Depression Drug (Zacks)
Sep-16-25 12:02AM	3 Reasons to Avoid SUPN and 1 Stock to Buy Instead (StockStory)
Aug-27-25 04:15PM	Supernus Pharmaceuticals to Participate in September Investor Conferences (GlobeNewswire)
Aug-13-25 12:12AM	5 Insightful Analyst Questions From Supernus Pharmaceuticals's Q2 Earnings Call (StockStory)
Aug-12-25 11:43PM	SUPN Q2 Deep Dive: Growth Drivers Shift to New Portfolio as Legacy Products Fade (StockStory)
Aug-11-25 08:00AM	Here's Third Avenue Small-Cap Value Fund's Update on Supernus Pharmaceuticals (SUPN) (Insider Monkey)
Aug-07-25 02:00PM	Supernus Pharmaceuticals Stock Scores RS Rating Upgrade (Investor's Business Daily)
Aug-06-25 01:20PM	Why Are Supernus Pharmaceuticals (SUPN) Shares Soaring Today (StockStory) +13.08%
03:27AM	Supernus Pharmaceuticals Inc (SUPN) Q2 2025 Earnings Call Highlights: Innovation and Strategic ... (GuruFocus.com)
Aug-05-25 08:30PM	Supernus (SUPN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
06:35PM	Supernus Pharmaceuticals (SUPN) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
06:18PM	Supernus Pharmaceuticals (NASDAQ:SUPN) Beats Expectations in Strong Q2, Guides for Strong Full-Year Sales (StockStory)
05:32PM	Supernus: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Supernus Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-03-25 11:08PM	Supernus Pharmaceuticals (SUPN) Reports Earnings Tomorrow: What To Expect (StockStory)
Aug-01-25 07:09AM	Supernus strengthens neuropsychiatric portfolio with Sage Therapeutics (Pharmaceutical Technology)
Jul-31-25 10:48AM	Biogen's Q2 Earnings & Sales Beat, 2025 Outlook Raised, Stock Up (Zacks)
08:44AM	Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics (GlobeNewswire)
Jul-30-25 04:05PM	Sage Therapeutics Announces Second Quarter 2025 Financial Results (Business Wire)
12:16PM	Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today (StockStory)
Jul-28-25 10:24AM	Biogen Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
08:25AM	Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer (GlobeNewswire)
Jul-24-25 11:33PM	Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN) (StockStory)
Jul-22-25 04:30PM	Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025 (GlobeNewswire)
Jul-18-25 03:10PM	Why Supernus Pharmaceuticals (SUPN) Shares Are Falling Today (StockStory)
Jul-14-25 12:31AM	1 Stock Under $50 with Exciting Potential and 2 to Turn Down (StockStory)
Jun-30-25 01:43PM	Sage to lay off most staff amid Supernus buyout (BioPharma Dive)
Jun-27-25 05:23AM	Supernus Pharmaceuticals's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-18-25 09:45AM	H.C. Wainwright sees potential competition for Sage from Biogen (TipRanks)
Jun-17-25 02:36PM	SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million Deal (Zacks)
09:16AM	Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus (TipRanks)
Jun-16-25 04:21PM	Supernus Pharmaceuticals Snaps Up Beleaguered Sage Therapeutics (Investor's Business Daily)
11:43AM	Supernus makes depression drug play with $795m Sage buyout (Pharmaceutical Technology)
09:16AM	Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million (Investor's Business Daily)
07:42AM	Sage Therapeutics Stock Soars 35% After Sale to Supernus Pharmaceuticals. What We Know. (Barrons.com)
07:00AM	Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio (GlobeNewswire)
May-29-25 08:30AM	Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree Content Series with Supernus Pharmaceuticals (GlobeNewswire)
May-28-25 04:05PM	Supernus to Participate in the 2025 Jefferies Global Healthcare Conference (GlobeNewswire)
04:05PM	Supernus Announces Paragraph IV ANDA Filings for Qelbree (GlobeNewswire)
May-20-25 08:30AM	Busy Philipps Empowers Women with ADHD to Go from Feeling Misrepresented to Being 'Ms. Represented' in First-of-its-Kind Campaign with Supernus Pharmaceuticals (GlobeNewswire)
May-14-25 02:29PM	Is the Options Market Predicting a Spike in Supernus Pharmaceuticals (SUPN) Stock? (Zacks)
May-07-25 03:20AM	Supernus Pharmaceuticals Inc (SUPN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
12:34AM	3 Stocks Under $50 That Concern Us (StockStory)
May-06-25 10:55PM	Supernus Pharmaceuticals, Inc. (SUPN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:00PM	Supernus (SUPN) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:30PM	Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Surpass Estimates (Zacks)
04:08PM	Supernus Announces First Quarter 2025 Financial Results (GlobeNewswire)
Apr-30-25 07:28AM	Supernus: New Direction Beckons After MDD Drug Fail (Rating Downgrade) (Seeking Alpha)
Apr-29-25 09:05AM	3 of Wall Street's Favorite Stocks with Questionable Fundamentals (StockStory)
Apr-28-25 12:00PM	What Makes Supernus (SUPN) a New Buy Stock (Zacks)
Apr-24-25 07:46AM	Johnson & Johnson Just Proved The Bears Wrong Again (Seeking Alpha)
Apr-23-25 05:14PM	Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025 (GlobeNewswire)
Apr-17-25 11:08AM	Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Pharma Stock to Buy for Long Term Growth? (Insider Monkey)
Apr-04-25 05:13AM	Supernus Pharmaceuticals (SUPN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-25-25 12:53PM	IBD 50's Axsome Therapeutics Dives On Mixed ADHD Results. Why Analysts Aren't Worried. (Investor's Business Daily)
Mar-17-25 09:35AM	Down -20.07% in 4 Weeks, Here's Why Supernus (SUPN) Looks Ripe for a Turnaround (Zacks)
Mar-14-25 05:01AM	Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks (StockStory)
Mar-13-25 09:00AM	3 Small-Cap Stocks Skating on Thin Ice (StockStory)
Mar-06-25 07:24PM	Supernus Pharmaceuticals, Inc. (SUPN): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts (Insider Monkey)
Mar-04-25 04:30PM	Supernus to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
04:06AM	Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks (StockStory)

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hudson Frederick M.	Director	Jan 09 '26	Option Exercise	12.98	15,000	194,700	61,307	Jan 12 04:09 PM
Mottola Frank	SVP, Chief Tech. Ops. Officer	Dec 19 '25	Option Exercise	28.82	20,000	576,500	30,496	Dec 22 04:04 PM
Mottola Frank	SVP, Chief Tech. Ops. Officer	Dec 19 '25	Sale	50.41	20,000	1,008,150	15,496	Dec 22 04:04 PM
FRANK MOTTOLA	Officer	Dec 19 '25	Proposed Sale	49.28	20,000	985,600		Dec 19 04:23 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Dec 18 '25	Option Exercise	0.00	1,500	0	15,218	Dec 19 04:05 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Dec 18 '25	Sale	44.44	710	31,552	14,508	Dec 19 04:05 PM
NEWHALL CHARLES W III	Director	Nov 21 '25	Option Exercise	12.98	15,000	194,700	119,644	Nov 24 06:16 PM
Khattar Jack A.	President, CEO	Oct 09 '25	Option Exercise	25.30	81,250	2,055,625	1,266,478	Oct 10 05:33 PM
Khattar Jack A.	President, CEO	Oct 09 '25	Sale	50.57	59,900	3,029,336	1,206,578	Oct 10 05:33 PM
NEWHALL CHARLES W III	Director	Oct 09 '25	Sale	50.77	25,000	1,269,234	104,644	Oct 10 04:21 PM
JACK A. KHATTAR	Director	Oct 09 '25	Proposed Sale	48.00	59,900	2,875,200		Oct 09 04:20 PM
CHARLES NEWHALL	Director	Oct 09 '25	Proposed Sale	48.00	25,000	1,200,000		Oct 09 04:19 PM
Khattar Jack A.	President, CEO	Oct 02 '25	Option Exercise	0.00	39,320	0	1,192,757	Oct 03 04:19 PM
Khattar Jack A.	President, CEO	Oct 02 '25	Option Exercise	25.30	2,267	57,355	1,163,137	Oct 03 04:18 PM
Khattar Jack A.	President, CEO	Oct 02 '25	Sale	48.06	1,904	91,506	1,161,233	Oct 03 04:18 PM
JACK A. KHATTAR	Director	Oct 02 '25	Proposed Sale	48.04	1,904	91,468		Oct 02 04:23 PM
Khattar Jack A.	President, CEO	Oct 01 '25	Option Exercise	25.30	53,785	1,360,760	1,201,043	Oct 02 04:02 PM
Khattar Jack A.	President, CEO	Oct 01 '25	Sale	48.07	40,173	1,931,116	1,160,870	Oct 02 04:02 PM
JACK A. KHATTAR	Director	Oct 01 '25	Proposed Sale	47.79	40,173	1,919,868		Oct 01 04:28 PM
Khattar Jack A.	President, CEO	Sep 30 '25	Option Exercise	25.30	11,510	291,203	1,155,846	Oct 01 04:20 PM
Khattar Jack A.	President, CEO	Sep 30 '25	Sale	48.25	8,588	414,371	1,147,258	Oct 01 04:20 PM
JACK A. KHATTAR	Director	Sep 30 '25	Proposed Sale	47.60	8,588	408,789		Sep 30 04:34 PM
Khattar Jack A.	President, CEO	Sep 29 '25	Option Exercise	25.30	13,688	346,306	1,154,571	Sep 30 04:24 PM
Khattar Jack A.	President, CEO	Sep 29 '25	Sale	48.02	10,235	491,485	1,144,336	Sep 30 04:24 PM
JACK A. KHATTAR	Director	Sep 29 '25	Proposed Sale	47.03	10,235	481,352		Sep 29 04:37 PM
Rubin Jonathan	SVP, Chief Medical Officer	Sep 25 '25	Option Exercise	0.00	1,875	0	11,855	Sep 26 04:17 PM
Khattar Jack A.	President, CEO	Sep 23 '25	Option Exercise	12.98	47,940	622,261	1,170,396	Sep 24 04:14 PM
Khattar Jack A.	President, CEO	Sep 23 '25	Sale	47.23	29,513	1,393,899	1,140,883	Sep 24 04:14 PM
Khattar Jack A.	President, CEO	Sep 22 '25	Option Exercise	12.98	27,060	351,239	1,139,043	Sep 23 04:22 PM
Khattar Jack A.	President, CEO	Sep 22 '25	Sale	47.02	16,587	779,921	1,122,456	Sep 23 04:22 PM
JACK A. KHATTAR	Director	Sep 23 '25	Proposed Sale	46.98	29,513	1,386,521		Sep 23 04:21 PM
JACK A KHATTAR	Officer	Sep 22 '25	Proposed Sale	46.04	16,587	763,665		Sep 22 04:26 PM
Mottola Frank	SVP, Chief Tech. Ops. Officer	Sep 12 '25	Option Exercise	39.40	5,000	197,000	20,496	Sep 15 05:39 PM
Mottola Frank	SVP, Chief Tech. Ops. Officer	Sep 12 '25	Sale	45.87	5,000	229,350	15,496	Sep 15 05:39 PM
FRANK MOTTOLA	Officer	Sep 12 '25	Proposed Sale	45.87	5,000	229,338		Sep 12 04:05 PM
Khattar Jack A.	President, CEO	Sep 08 '25	Option Exercise	25.30	8,074	204,272	1,118,305	Sep 09 04:21 PM
Khattar Jack A.	President, CEO	Sep 08 '25	Sale	46.29	6,322	292,645	1,111,983	Sep 09 04:21 PM
Khattar Jack A.	President, CEO	Sep 05 '25	Option Exercise	25.30	73,176	1,851,353	1,165,809	Sep 08 04:31 PM
Khattar Jack A.	President, CEO	Sep 05 '25	Sale	46.01	55,578	2,557,144	1,110,231	Sep 08 04:31 PM
JACK A KHATTAR	Officer	Sep 08 '25	Proposed Sale	46.00	6,322	290,812		Sep 08 04:28 PM
JACK A KHATTAR	Director	Sep 05 '25	Proposed Sale	45.43	55,578	2,524,909		Sep 05 04:25 PM
Khattar Jack A.	President, CEO	Aug 28 '25	Option Exercise	12.98	38,779	503,351	1,116,783	Aug 29 04:05 PM
Khattar Jack A.	President, CEO	Aug 27 '25	Option Exercise	12.98	17,195	223,191	1,088,654	Aug 29 04:05 PM
Khattar Jack A.	President, CEO	Aug 28 '25	Sale	45.12	24,150	1,089,648	1,092,633	Aug 29 04:05 PM
Khattar Jack A.	President, CEO	Aug 27 '25	Sale	45.05	10,650	479,782	1,078,004	Aug 29 04:05 PM
NEWHALL CHARLES W III	Director	Aug 27 '25	Sale	45.01	3,588	161,496	129,644	Aug 29 04:05 PM
JACK A KHATTAR	Director	Aug 28 '25	Proposed Sale	45.07	24,150	1,088,440		Aug 28 04:23 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Aug 25 '25	Option Exercise	0.00	1,250	0	14,299	Aug 27 05:01 PM
Mottola Frank	SVP, Quality, GMP, Ops, IT	Aug 25 '25	Option Exercise	12.98	14,000	181,720	29,496	Aug 27 04:59 PM
Mottola Frank	SVP, Quality, GMP, Ops, IT	Aug 25 '25	Sale	44.51	14,000	623,140	15,496	Aug 27 04:59 PM
NEWHALL CHARLES W III	Director	Aug 25 '25	Sale	45.00	1,000	45,000	133,232	Aug 27 04:56 PM
Khattar Jack A.	President, CEO	Aug 25 '25	Option Exercise	12.98	1,611	20,911	1,072,459	Aug 27 04:56 PM
Khattar Jack A.	President, CEO	Aug 25 '25	Sale	45.00	1,000	45,000	1,071,459	Aug 27 04:56 PM
JACK A KHATTAR	Director	Aug 27 '25	Proposed Sale	44.32	10,650	472,008		Aug 27 04:28 PM
NEWHALL CHARLES W III	Director	Aug 22 '25	Sale	45.00	1,412	63,540	134,232	Aug 26 04:19 PM
DEC TIMOTHY C	Senior Vice-President & CFO	Aug 22 '25	Sale	44.49	11,780	524,092	1,246	Aug 26 04:18 PM
Khattar Jack A.	President, CEO	Aug 22 '25	Option Exercise	12.98	2,415	31,347	1,072,348	Aug 26 04:08 PM
Khattar Jack A.	President, CEO	Aug 22 '25	Sale	45.00	1,500	67,500	1,070,848	Aug 26 04:08 PM
JACK A KHATTAR	Director	Aug 25 '25	Proposed Sale	44.88	1,000	44,880		Aug 25 04:38 PM
CHARLES NEWHALL	Director	Aug 25 '25	Proposed Sale	44.88	4,588	205,909		Aug 25 04:37 PM
FRANK MOTTOLA	Officer	Aug 25 '25	Proposed Sale	44.51	14,000	623,070		Aug 25 04:09 PM
CHARLES NEWHALL	Director	Aug 22 '25	Proposed Sale	43.32	1,412	61,168		Aug 22 05:04 PM
JACK A KHATTAR	Director	Aug 22 '25	Proposed Sale	43.32	1,500	64,980		Aug 22 04:47 PM
TIMOTHY CARROLL DEC	Officer	Aug 22 '25	Proposed Sale	44.49	11,780	524,133		Aug 22 04:26 PM
Sensenig Bethany	Director	Aug 14 '25	Sale	42.25	5,369	226,840	0	Aug 18 04:31 PM
Hudson Frederick M.	Director	Aug 14 '25	Sale	42.26	7,457	315,133	46,307	Aug 18 04:28 PM
FREDERICK M HUDSON	Director	Aug 14 '25	Proposed Sale	42.26	7,457	315,116		Aug 14 04:33 PM
BETHANY SENSENIG	Director	Aug 14 '25	Proposed Sale	42.64	5,369	228,934		Aug 14 04:22 PM
Khattar Jack A.	President, CEO	Aug 06 '25	Option Exercise	17.95	201,250	3,613,225	1,133,433	Aug 08 04:40 PM
Khattar Jack A.	President, CEO	Aug 06 '25	Sale	42.02	140,000	5,883,360	1,030,183	Aug 08 04:40 PM
JACK A KHATTAR	Director	Aug 06 '25	Proposed Sale	37.53	140,000	5,254,200		Aug 06 04:23 PM
Khattar Jack A.	President, CEO	Mar 10 '25	Option Exercise	0.00	35,000	0	1,008,638	Mar 11 04:17 PM
DEC TIMOTHY C	Senior Vice-President & CFO	Mar 10 '25	Option Exercise	0.00	3,800	0	13,636	Mar 11 04:15 PM
Khattar Jack A.	President, CEO	Mar 07 '25	Option Exercise	0.00	38,640	0	992,219	Mar 07 04:40 PM
Mottola Frank	SVP, Quality, GMP, Ops, IT	Mar 07 '25	Option Exercise	0.00	2,625	0	16,507	Mar 07 04:34 PM
Mottola Frank	SVP, Quality, GMP, Ops, IT	Feb 26 '25	Option Exercise	0.00	5,760	0	17,683	Feb 26 05:56 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Feb 21 '25	Option Exercise	0.00	1,650	0	11,799	Feb 24 08:22 PM
Rubin Jonathan	SVP, Chief Medical Officer	Feb 21 '25	Option Exercise	0.00	1,875	0	8,780	Feb 24 08:20 PM
Rubin Jonathan	SVP, Chief Medical Officer	Feb 21 '25	Sale	39.15	927	36,292	7,853	Feb 24 08:20 PM
Mottola Frank	SVP, Quality, GMP, Ops, IT	Feb 21 '25	Option Exercise	0.00	1,125	0	9,576	Feb 24 08:18 PM

Open in Screener

TSLA

Tesla Inc

Feb 13 • 04:00PM ET

417.44

+0.37 0.09 %

Consumer Cyclical • Auto Manufacturers • USA • NASD

Peers: LI XPEV NIO RIVN LCID TM HMC GM STLA F

| Held by: VTI VOO QQQ IVV SPY VUG XLY IWF QQQM SCHG

Index	NDX, S&P 500	P/E	387.96	EPS (ttm)	1.08	Insider Own	28.17%	Shs Outstand	3.75B	Perf Week	1.54%
Market Cap	1566.42B	Forward P/E	159.48	EPS next Y	2.62	Insider Trans	0.21%	Shs Float	2.39B	Perf Month	-4.95%
Enterprise Value	1537.41B	PEG	5.34	EPS next Q	0.42	Inst Own	48.78%	Short Float	2.69%	Perf Quarter	-3.06%
Income	3.79B	P/S	16.52	EPS this Y	19.65%	Inst Trans	0.62%	Short Ratio	0.90	Perf Half Y	24.39%
Sales	94.83B	P/B	19.06	EPS next Y	31.78%	ROA	2.92%	Short Interest	64.37M	Perf YTD	-7.18%
Book/sh	21.90	P/C	35.24	EPS next 5Y	29.89%	ROE	4.89%	52W High	498.83 -16.32%	Perf Year	17.28%
Cash/sh	11.85	P/FCF	251.84	EPS past 3/5Y	-33.28% 38.32%	ROIC	4.02%	52W Low	214.25 94.84%	Perf 3Y	114.47%
Dividend Est.	-	EV/EBITDA	139.80	Sales past 3/5Y	5.19% 24.63%	Gross Margin	18.03%	Volatility	3.67% 3.49%	Perf 5Y	53.45%
Dividend TTM	-	EV/Sales	16.21	EPS Y/Y TTM	-47.22%	Oper. Margin	5.11%	ATR (14)	16.07	Perf 10Y	4045.66%
Dividend Ex-Date	-	Quick Ratio	1.77	Sales Y/Y TTM	-2.93%	Profit Margin	4.00%	RSI (14)	44.92	Recom	2.57
Dividend Gr. 3/5Y	- -	Current Ratio	2.16	EPS Q/Q	-63.92%	SMA20	-1.72%	Beta	1.89	Target Price	426.86
Payout	0.00%	Debt/Eq	0.18	Sales Q/Q	-3.14%	SMA50	-5.97%	Rel Volume	0.72	Prev Close	417.07
Employees	134785	LT Debt/Eq	0.15	Earnings	Jan 28 AMC	SMA200	8.38%	Avg Volume	71.56M	Price	417.44
IPO	Jun 29, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.82% 0.65%	Trades		Volume	51,263,097	Change	0.09%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-12-26	Resumed	Tigress Financial	Buy	$550
Jan-30-26	Reiterated	JP Morgan	Underweight	$150 → $145
Jan-12-26	Reiterated	Wells Fargo	Underweight	$120 → $130
Jan-02-26	Reiterated	Truist	Hold	$444 → $439
Dec-08-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$425
Oct-29-25	Reiterated	BofA Securities	Neutral	$341 → $471
Oct-23-25	Reiterated	Truist	Hold	$280 → $406
Oct-23-25	Reiterated	Mizuho	Outperform	$450 → $485
Oct-23-25	Reiterated	Deutsche Bank	Buy	$435 → $440
Oct-23-25	Reiterated	Canaccord Genuity	Buy	$490 → $482
Oct-16-25	Reiterated	Barclays	Equal Weight	$275 → $350
Oct-16-25	Initiated	BNP Paribas Exane	Underperform	$307
Oct-13-25	Initiated	Melius	Buy	$520
Oct-10-25	Reiterated	RBC Capital Mkts	Outperform	$325 → $500
Oct-09-25	Reiterated	TD Cowen	Buy	$374 → $509
Oct-08-25	Reiterated	Stifel	Buy	$440 → $483
Sep-30-25	Reiterated	Canaccord Genuity	Buy	$333 → $490
Sep-26-25	Reiterated	Deutsche Bank	Buy	$345 → $435
Sep-23-25	Reiterated	Mizuho	Outperform	$375 → $450
Sep-22-25	Reiterated	Piper Sandler	Overweight	$400 → $500

Show Previous Ratings

Today 02:06PM	The Week in EV Stocks: Rivian Gains 19.8% While Tesla Lags Behind \| RIVN, TSLA (24/7 Wall St.)
01:32PM	Tesla Rival Xiaomi's YU7 SUV Overtakes Model Y China Sales In January (Benzinga)
12:00PM	Here are 7 charts guaranteed to stress you out about the stock market (MarketWatch)
10:00AM	Consumer Tech News (Feb 9-13): AI Energy Push, And Mixed Tech Earnings Dominate Headlines & More (Benzinga)
08:10AM	ARKK ETF Update (24/7 Wall St.)
06:17AM	Loading…
06:17AM	Elon Musk Says Tesla Will Have 'Largest Fleet' Of Autonomous Vehicles As Far Into The Future As He Can Imagine (Benzinga)
06:14AM	Tesla Expands AI Chip Design Efforts To South Korea, Actively Recruits Engineers (Benzinga)
04:36AM	DOJ Sends Letter To Congress Listing Hundreds Of Names Mentioned In Epstein Files (Benzinga)
Feb-14-26 10:57PM	Cathie Wood Says Tesla's Optimus Could Transform Factory, Home Life By 2028-2029 (Benzinga)
05:00PM	Ford and GM Join Tesla in the Energy Storage Race (Oilprice.com)
02:21PM	Apple News Bias Alleged, FTC Warns Tim Cook, EssilorLuxottica Discloses Ray-Ban Meta Sales (Above Avalon)
02:01PM	Elon Musk Warns Tesla's $25K Cybercab Will Be 'Agonizingly Slow' At First Even As He Targets 2M Robotaxis A Year (Benzinga)
01:11PM	Offering a Cup of FUD Seems Desperate (AVALON Podcast) (Above Avalon)
01:07PM	New Tesla vision sounds almost too good to be true (TheStreet)
10:37AM	AI productivity has an 'intense' downside, new study says (TheStreet)
09:23AM	Loading…
09:23AM	Amazon and Microsoft Enter Bear Markets: Whats Breaking the Magnificent 7? (24/7 Wall St.)
09:22AM	Tesla's (TSLA) 'Investment Year' Strategy Is Turning Heads on Wall Street (Insider Monkey)
08:08AM	Billionaire George Soros Just Made Big, Bold Bets on 2 AI Stocks (24/7 Wall St.)
08:02AM	GameStop, Palantir, Tesla And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week (Benzinga)
07:00AM	We get the living daylights taxed out of us: How billionaires like Elon Musk avoid taxes on their massive wealth (Moneywise)
06:46AM	In Musk We Trust? Tesla CEO Bets Mass And Energy Will Replace US Dollar As Future Currency (Benzinga)
04:30AM	Why would Tesla want to build 100 GW of solar manufacturing capacity? (Investing.com)
Feb-13-26 11:44PM	DOGE Open-Sources Largest Medicaid Dataset In Agency History As Elon Musk Touts Transparency Move: 'It's A State Of Mind' (Benzinga)
10:46PM	Stellantis Has Stalled. The Stock Can Kick Into High Gear Again. (Barrons.com)
10:10PM	Pentagon Adds Alibaba, BYD To Chinese Military List, Then Reportedly Pulls Filing As Trump-Xi Meet Looms (Benzinga)
05:35PM	Tesla is still a 'long way off' from functional humanoid robots (Yahoo Finance Video)
04:19PM	Tesla Stock Edges Up. Friday the 13th Was a Winner. (Barrons.com)
02:32PM	Congresswoman, xAI Stakeholder Invests In Tesla Robotics Rival Apptronik: Betting On Musk And Against Him? (Benzinga)
02:25PM	SpaceX reportedly mulls dual-class share structure for upcoming IPO (Investing.com)
02:14PM	SpaceX considering dual-class shares in IPO, Bloomberg News reports (Reuters)
01:52PM	Loading…
01:52PM	Why Long-Term Tesla Shareholders Are Finally Walking Away in 2026 (24/7 Wall St.)
01:30PM	Space exec. weighs in on SpaceX IPO, xAI merger (Yahoo Finance Video)
12:31PM	Maye Musk Says She's A 'Proud Mom' As Elon Musk Tops List Of 'America's Greatest Innovators,' Beats Jeff Bezos And Jensen Huang (Benzinga)
12:14PM	Crypto Trader To Tesla Bulls: 'Give Me One Reason Why TSLA Is Worth $1.3 Trillion' (Benzinga)
11:19AM	Tesla's Rally Setup Is Here-But Valuation Makes It Fragile (MarketBeat)
11:12AM	Crocs Regains Its Footing. Charts Point to More Upside (Barrons.com)
10:46AM	Detroit Automakers Take $50 Billion Hit as EV Bubble Bursts (The Wall Street Journal)
10:06AM	Rivian: Buy or Hold? Deutsche Bank turns bullish, UBS cautious (Investing.com)
09:02AM	Rivian Stock Disaster Continues (24/7 Wall St.)
09:00AM	Tesla, Inc. (TSLA) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:45AM	In Musk We Trust? Tesla CEO Bets Mass And Energy Will Replace US Dollar As Future Currency (Benzinga)
08:31AM	Amazon, Google And Others Are Pouring $700 Billion Into AI CapEx, Top Analyst Explains Why This Makes It 'Hard' To Bet Against Nvidia (Benzinga)
07:42AM	Amazon Joins Microsoft in Bear Market. Why Mag 7 Stocks Are Struggling. (Barrons.com)
07:32AM	Rivian Surges On Upgrades As Attention Turns To Its New Tesla Model Y Competitor (Investor's Business Daily)
07:17AM	Tesla Stock Is Down. How It Trades on Friday the 13th. (Barrons.com)
06:21AM	Cooler January CPI Signals an Inflation Thaw (Barchart)
06:21AM	Waymo Unveils 6th-Gen Driver, Eyes Scale (GuruFocus.com)
05:00AM	Big Tech sees big tax break fuel AI spending under Trump tax law (Quartz)
03:13AM	Tesla Rival Xiaomi's YU7 SUV Overtakes Model Y China Sales In January (Benzinga)
Feb-12-26 11:47PM	Bernie Sanders Questions Jeff Bezos' Motives Over Amazon's $200 Billion AI Spending: 'What A Surprise' (Benzinga)
11:16PM	EV Market Hits Speed Bump: China Sales Slide 20%, US Sees Worst Month Since 2022 (Benzinga)
10:49PM	Tesla Taiwan says no immediate price changes for US-made models, pledges after-sales support as tariff framework awaits implementation (DigiTimes)
09:00PM	Detroit Automakers Take $50 Billion Hit as EV Bubble Bursts (The Wall Street Journal)
07:12PM	Elon Musk slams Anthropic AI models as 'misanthropic and evil' in scathing social media post (Fox Business)
04:10PM	Teslas Latest Buy Rating Fails To Lift Stock for 5th Day (Barrons.com)
04:09PM	LiveOne Inc (LVO) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
02:31PM	Tesla To Charge $300,000 For Long-Range Semi, Undercutting Rivals By Over $145,000: Report (Benzinga)
02:06PM	Apple, Nvidia And Other 8 Tech Stocks Just Wiped Out $500 Billion As A New Threat Emerges (Benzinga)
02:01PM	Trump Scraps EPA Climate Rules. Auto Makers Face Winners and Losers. (Barrons.com)
01:38PM	4,500 Reasons to Buy Amazon Stock Today (Barchart)
01:23PM	Tom Lee Says AI Killed Software And Job Losses Are 'Soon To Follow' (Benzinga)
01:02PM	LiveOne Q3 Earnings Call Highlights (MarketBeat)
12:01PM	Elon Musk Warns Tesla's $25K Cybercab Will Be 'Agonizingly Slow' At First Even As He Targets 2M Robotaxis A Year (Benzinga)
11:04AM	Is a $2 Billion Buyback Enough to Buy Shopify Stock Here? (Barchart)
11:01AM	More Tesla, xAI Execs ResignWhy Leaders Keep Ditching Elon Musk (Benzinga)
10:31AM	Elon Musk Bets On Humanoid Robots In 2026, But One Company Hopes 'Elon Time' Strikes Again (Benzinga)
10:25AM	Waymo eyes 1 million paid rides per week as expansion accelerates, co-CEO says (Investing.com)
10:16AM	The Great Distortion: 1,500 Stocks Vs. The Magnificent 7 In Norway's Massive U.S. Equity Portfolio (Benzinga)
09:00AM	Half Of xAIs Founders Are Gone as Musk Hires for the Moon (Moby)
08:13AM	Mag 7 AI Arms Race: Heavy Capex, FCF Strain and One Clear Winner (Zacks)
07:15AM	Tesla Stock Rises. It's Going for a 5-Day Winning Streak. (Barrons.com)
05:36AM	The godfather of AI predicts mass unemployment is on its way. This CEO warns even a 10% reduction will feel like a depression (Fortune)
02:02AM	Elon Musk Says 'Maybe We'll Meet Aliens,' Reaffirms Lunar Mass Driver, Deep-Space AI Satellite Goals (Benzinga)
01:30AM	The Allure of Chinese Tech Stocks. A Pro Picks 7 Names. (Barrons.com)
12:07AM	Gary Black Rejects Elon Musk-Led Tesla's Discount-First Communications Strategy: 'I Don't Think…' (Benzinga)
Feb-11-26 10:01PM	Amazon, Google And Others Are Pouring $700 Billion Into AI CapEx, Top Analyst Explains Why This Makes It 'Hard' To Bet Against Nvidia (Benzinga)
08:55PM	Maye Musk Says She's A 'Proud Mom' As Elon Musk Tops List Of 'America's Greatest Innovators,' Beats Jeff Bezos And Jensen Huang (Benzinga)
06:52PM	Vatican Bank Is Picking Stocks - And It Likes Meta, Amazon The Most (Benzinga)
06:01PM	Catherine Wood's Strategic Moves: A Closer Look at Tesla Inc's Portfolio Impact (GuruFocus.com)
04:15PM	Tesla Stock Targets 4-Day Winning Run. The Solar Business Is In Focus. (Barrons.com)
04:00PM	Morgan Stanley Sees $190 Billion Upside in Teslas Solar Ambitions (Oilprice.com)
03:11PM	Elon Musk's latest promises: Moon cities and space catapults (Quartz)
02:31PM	Elon Musk Says He Would 'Congratulate' Jeff Bezos For Reaching Moon First Touts SpaceX's Lunar City Bid (Benzinga)
01:31PM	After He Sold His First Company, Elon Musk Chose A McLaren F1 Instead Of A House. The Choice Ties Directly To The Elusive Tesla Roadster (Benzinga)
01:26PM	Rivian R2 Early Reviews Are In: Marques Brownlee Says New EV 'Can Be Their Model Y' (Benzinga)
12:18PM	Tesla Stock Rises -- Morgan Stanley Sees $50B Upside From Solar Ambitions (GuruFocus.com)
11:46AM	Tesla (TSLA) Draws Fresh Attention as Morgan Stanley Highlights Solar Opportunity (Insider Monkey)
11:45AM	Musk's Boring Co. proposes $34M tunnel deal with Nashville airport (The Tennessean)
11:35AM	xAI Loses Second Co-Founder in Days (GuruFocus.com)
11:30AM	Big Tech stocks are mostly down, weighing on S&P 500 (MarketWatch)
10:44AM	Can NIO Monetize Its 100M Battery Swap Milestone in 2026? (Zacks)
09:30AM	As Tesla Loses in Europe, Here Is What Investors Need for TSLA Stock to Win in 2026 (Barchart)
09:00AM	Humanoid startup Apptronik raises $520 million with backing from Google and Mercedes-Benz (Reuters)
08:31AM	Tesla Says FSD Service Would Be Taken Into Account When Trading In Model S, X, Cyberbeast Trims With Luxe Package (Benzinga)
08:27AM	Baron Partners Fund Trimmed Tesla (TSLA) Despite Increased Confidence (Insider Monkey)
08:05AM	Tesla Partners With Tencent to Bring Smarter In Car Tech to China (GuruFocus.com)
08:03AM	Tesla vs. BYD: Valuations Widen As 'Growth Paths Clearly Differ,' HSBC Says (Investor's Business Daily)
07:14AM	Tesla Stock Targets 4-Day Winning Run. Why Musk's SpaceX Is Stealing Focus. (Barrons.com)
07:00AM	Long Call Butterfly Trade Ideas for February 11th (Barchart)
07:00AM	AI mania is now spilling into space (The Telegraph)

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MURDOCH JAMES R	Director	Jan 02 '26	Sale	445.40	60,000	26,723,781	577,031	Jan 06 07:00 PM
James Murdoch	Affiliate	Jan 02 '26	Proposed Sale	449.72	60,000	26,983,200		Jan 02 04:45 PM
Musk Kimbal	Director	Dec 09 '25	Sale	450.66	56,820	25,606,501	1,391,615	Dec 11 07:00 PM
Taneja Vaibhav	Chief Financial Officer	Dec 05 '25	Option Exercise	0.00	6,538	0	16,394	Dec 09 07:00 PM
Taneja Vaibhav	Chief Financial Officer	Dec 08 '25	Sale	443.93	2,637	1,170,635	13,757	Dec 09 07:00 PM
Kimbal Musk	Director	Dec 09 '25	Proposed Sale	439.58	56,820	24,976,936		Dec 09 04:41 PM
VAIBHAV TANEJA	Officer	Dec 08 '25	Proposed Sale	443.93	2,637	1,170,635		Dec 08 06:07 PM
MURDOCH JAMES R	Director	Sep 15 '25	Sale	422.68	60,000	25,360,800	637,031	Sep 17 07:00 PM
James Murdoch	Affiliate	Sep 15 '25	Proposed Sale	395.94	60,000	23,756,400		Sep 15 05:33 PM
Musk Elon	CEO	Sep 12 '25	Buy	389.28	2,568,732	999,959,042	413,362,808	Sep 15 06:01 AM
Zhu Xiaotong	SVP, APAC and	Sep 11 '25	Sale	363.75	20,000	7,275,100	47,600	Sep 12 06:48 PM
MAGICAL BLAKE GLOBAL LIMITED	Officer	Sep 11 '25	Proposed Sale	363.76	20,000	7,275,102		Sep 11 04:13 PM
Taneja Vaibhav	Chief Financial Officer	Sep 05 '25	Option Exercise	0.00	6,538	0	12,462	Sep 09 07:00 PM
Taneja Vaibhav	Chief Financial Officer	Sep 08 '25	Sale	352.38	2,606	918,137	9,856	Sep 09 07:00 PM
VAIBHAV TANEJA	Officer	Sep 08 '25	Proposed Sale	352.38	2,606	918,311		Sep 08 04:15 PM
MURDOCH JAMES R	Director	Aug 26 '25	Sale	350.29	120,000	42,034,320	697,031	Aug 28 07:00 PM
James Murdoch	Affiliate	Aug 26 '25	Proposed Sale	346.60	120,000	41,592,000		Aug 26 05:12 PM
MURDOCH JAMES R	Director	Jul 11 '25	Option Exercise	17.47	90,000	1,572,300	90,000	Jul 15 07:30 PM
Taneja Vaibhav	Chief Financial Officer	Jul 07 '25	Option Exercise	18.22	4,000	72,880	9,924	Jul 09 08:12 PM
Taneja Vaibhav	Chief Financial Officer	Jul 08 '25	Option Exercise	18.22	2,000	36,440	7,924	Jul 09 08:12 PM
Taneja Vaibhav	Chief Financial Officer	Jul 07 '25	Sale	292.89	4,000	1,171,545	5,924	Jul 09 08:12 PM
Taneja Vaibhav	Chief Financial Officer	Jul 08 '25	Sale	300.00	2,000	600,000	5,924	Jul 09 08:12 PM
VAIBHAV TANEJA	Officer	Jul 08 '25	Proposed Sale	293.94	2,000	587,880		Jul 08 04:21 PM
VAIBHAV TANEJA	Officer	Jul 07 '25	Proposed Sale	315.35	4,000	1,261,400		Jul 07 04:13 PM
Zhu Xiaotong	SVP, APAC	Jun 12 '25	Option Exercise	20.57	15,000	308,550	82,600	Jun 16 07:59 PM
Zhu Xiaotong	SVP, APAC	Jun 12 '25	Sale	323.81	15,000	4,857,105	67,600	Jun 16 07:59 PM
Xiaotong Zhu	Officer	Jun 12 '25	Proposed Sale	323.81	15,000	4,857,111		Jun 12 05:03 PM
Taneja Vaibhav	Chief Financial Officer	Jun 05 '25	Option Exercise	0.00	6,538	0	8,488	Jun 09 07:59 PM
Taneja Vaibhav	Chief Financial Officer	Jun 09 '25	Sale	285.71	2,564	732,573	5,924	Jun 09 07:59 PM
VAIBHAV TANEJA	Officer	Jun 09 '25	Proposed Sale	285.71	2,564	732,572		Jun 09 05:18 PM
Taneja Vaibhav	Chief Financial Officer	Jun 02 '25	Option Exercise	18.22	6,000	109,320	7,950	Jun 04 09:00 PM
Taneja Vaibhav	Chief Financial Officer	Jun 03 '25	Option Exercise	18.22	1,000	18,220	2,950	Jun 04 09:00 PM
Taneja Vaibhav	Chief Financial Officer	Jun 02 '25	Sale	341.02	6,000	2,046,092	1,950	Jun 04 09:00 PM
Taneja Vaibhav	Chief Financial Officer	Jun 03 '25	Sale	350.00	1,000	350,000	1,950	Jun 04 09:00 PM
VAIBHAV TANEJA	Officer	Jun 03 '25	Proposed Sale	342.69	1,000	342,690		Jun 03 04:26 PM
VAIBHAV TANEJA	Officer	Jun 02 '25	Proposed Sale	346.46	6,000	2,078,760		Jun 02 04:31 PM
Ehrenpreis Ira Matthew	Director	May 27 '25	Option Exercise	23.85	761,961	18,170,096	1,332,966	May 29 07:02 PM
Ehrenpreis Ira Matthew	Director	May 27 '25	Sale	357.30	477,572	170,636,358	855,394	May 29 07:02 PM
Musk Kimbal	Director	May 27 '25	Option Exercise	24.73	91,588	2,264,971	1,554,808	May 29 07:00 PM
Musk Kimbal	Director	May 27 '25	Sale	357.39	91,588	32,732,230	1,463,220	May 29 07:00 PM
IRA EHRENPREIS	Director	May 27 '25	Proposed Sale	339.34	477,572	162,059,282		May 27 04:41 PM
Kimbal Musk	Affiliate	May 27 '25	Proposed Sale	339.34	91,588	31,079,472		May 27 04:34 PM
Taneja Vaibhav	Chief Financial Officer	May 16 '25	Option Exercise	18.22	3,000	54,660	29,950	May 20 07:24 PM
Taneja Vaibhav	Chief Financial Officer	May 16 '25	Sale	350.11	3,000	1,050,336	26,950	May 20 07:24 PM
VAIBHAV TANEJA	Officer	May 16 '25	Proposed Sale	342.82	3,000	1,028,460		May 16 04:12 PM
Taneja Vaibhav	Chief Financial Officer	May 09 '25	Option Exercise	18.22	4,000	72,880	30,950	May 13 07:47 PM
Taneja Vaibhav	Chief Financial Officer	May 09 '25	Sale	300.00	4,000	1,200,000	26,950	May 13 07:47 PM
VAIBHAV TANEJA	Officer	May 09 '25	Proposed Sale	284.82	4,000	1,139,280		May 09 04:20 PM
DENHOLM ROBYN M	Director	May 06 '25	Option Exercise	24.73	112,395	2,779,528	197,395	May 08 07:00 PM
DENHOLM ROBYN M	Director	May 06 '25	Sale	274.12	112,395	30,809,625	85,000	May 08 07:00 PM
DENHOLM ROBYN M	Director	May 06 '25	Proposed Sale	274.12	112,395	30,809,645		May 06 10:55 AM
Taneja Vaibhav	Chief Financial Officer	May 01 '25	Option Exercise	18.22	4,000	72,880	30,950	May 05 09:33 PM
Taneja Vaibhav	Chief Financial Officer	May 01 '25	Sale	284.40	4,000	1,137,599	26,950	May 05 09:33 PM
DENHOLM ROBYN M	Director	Apr 29 '25	Option Exercise	24.73	112,390	2,779,405	197,390	May 01 07:00 PM
DENHOLM ROBYN M	Director	Apr 29 '25	Sale	285.58	112,390	32,096,717	85,000	May 01 07:00 PM
VAIBHAV TANEJA	Officer	May 01 '25	Proposed Sale	282.16	4,000	1,128,640		May 01 04:58 PM
DENHOLM ROBYN M	Director	Apr 29 '25	Proposed Sale	285.58	112,390	32,096,695		Apr 29 11:00 AM
Gebbia Joseph	Director	Apr 24 '25	Buy	256.31	4,000	1,025,232	4,111	Apr 28 06:45 PM
Taneja Vaibhav	Chief Financial Officer	Apr 07 '25	Option Exercise	18.22	4,000	72,880	30,950	Apr 09 07:35 PM
Taneja Vaibhav	Chief Financial Officer	Apr 07 '25	Sale	250.00	4,000	1,000,000	26,950	Apr 09 07:35 PM
VAIBHAV TANEJA	Officer	Apr 07 '25	Proposed Sale	239.43	4,000	957,720		Apr 07 04:26 PM
MURDOCH JAMES R	Director	Mar 10 '25	Option Exercise	24.43	531,787	12,992,693	531,787	Mar 12 07:12 PM
MURDOCH JAMES R	Director	Mar 10 '25	Sale	240.79	54,776	13,189,403	477,011	Mar 12 07:12 PM
MURDOCH JAMES R	Director	Mar 10 '25	Proposed Sale	240.79	54,776	13,189,411		Mar 10 02:49 PM
Taneja Vaibhav	Chief Financial Officer	Mar 05 '25	Option Exercise	0.00	6,538	0	29,622	Mar 06 08:40 PM
Taneja Vaibhav	Chief Financial Officer	Mar 06 '25	Sale	268.73	2,672	718,111	26,950	Mar 06 08:40 PM
VAIBHAV TANEJA	Officer	Mar 06 '25	Proposed Sale	268.73	2,673	718,312		Mar 06 05:48 PM
Taneja Vaibhav	Chief Financial Officer	Mar 03 '25	Option Exercise	18.22	6,000	109,320	29,084	Mar 05 09:44 PM
Taneja Vaibhav	Chief Financial Officer	Mar 03 '25	Sale	296.02	6,000	1,776,112	23,084	Mar 05 09:44 PM
DENHOLM ROBYN M	Director	Mar 03 '25	Option Exercise	24.73	112,390	2,779,405	197,390	Mar 05 07:01 PM
DENHOLM ROBYN M	Director	Mar 03 '25	Sale	299.61	112,390	33,672,976	85,000	Mar 05 07:01 PM
VAIBHAV TANEJA	Officer	Mar 03 '25	Proposed Sale	292.98	6,000	1,757,880		Mar 03 04:35 PM
DENHOLM ROBYN M	Director	Mar 03 '25	Proposed Sale	299.61	112,390	33,672,964		Mar 03 11:07 AM

GRFS

Grifols SA ADR

SUPN

Supernus Pharmaceuticals Inc

TSLA

Tesla Inc

Upgrade your FINVIZ experience